直接从制造商处购买。批量供应。
MW:90,000 至 92,000 Da 消光系数:1.71
从 20 mM Tris-HCl,pH 7.5 和 2 mM EDTA 冻干
发现浓度为 12 mg/ 100 毫升正常血浆。它是参与纤维蛋白溶解的丝氨酸蛋白酶纤溶酶的前体。
活性:>= 120 单位/毫克蛋白质。一个单位定义为在 37oC,pH 8.0 条件下 30 分钟内水解 1 umole N-甲苯磺酰基-L 精氨酸甲酯的酶量。
储存:<= -20°C
纯度:>=95%(通过 SDS-PAGE)
由对 HBsAg、抗-HCV、抗-HBc 无反应且对抗-HIV 1 和 2 呈阴性的血浆制备通过 FDA 要求的测试。
Athens Research & Technology 产品是实验室试剂,不得用于人类或用于任何药物目的。用于研究或进一步制造 use only.
Product Citation: Xu, Bo, Kun-ping Li, Fei Shen, Huan-qing Xiao, Wen-song Cai, Jiang-lin Li, Qi-cai Liu, and Lin Jia. \"乌司他丁通过抗纤维蛋白溶解途径抑制 MMP-9 激活,从而减少结肠癌肝转移切除术后的癌症复发。BioMed research international 2013 (2013)。
我们的产品和信息凝血因子酶和抑制剂免疫球蛋白脂蛋白和载脂蛋白低内毒素水平蛋白质牛奶和血小板蛋白质N嗜中性粒细胞蛋白质转铁蛋白和脱辅基转铁蛋白运输/其他蛋白质所有人类蛋白质所有动物蛋白质抗体检测试剂盒重组体查看所有产品纤溶酶原、人血浆的凝胶扫描This information代表 ART 准备的产品,但不是特定批次。苏州蚂蚁淘生物科技有限公司成立于2017年,致力于将全球领先的创新产品和前沿技术带入中国,帮助国内科研工作者在第一时间接触世界范围内的技术革命,并分享研发工具的进步带来的技术红利。依托于集团公司深厚的资源和超过400家的国内优质客户群体,生命科学领域的一站式供应链体系,以及高风险生物危险材料进出口平台的优势,蚂蚁淘生物严格筛选国际创新且经过同行验证过的产品和技术,引入中国市场,开发、孵育和推广。公司的未来将立足于实验室大数据整合和电子商务,结合严格的品牌筛选、创新的营销模式、专注的应用支持和坚实服务,帮助实现生命科学产业链的简单和高效。
特色产品
PRODUCTNUMBER:
16-16-120101
500ug$125
1mg$215
ApolipoproteinAI,HumanPlasma
人载脂蛋白AI
MW:28,000ExtinctionCoefficient:1.22
Frozenin10mMNH4HCO3,pH7.4
Storage:-70°Corlower
BuyPurifiedNativeHumanApolipoproteinAI(ApoA1),HumanPlasma.BulkQtyAvailable.
75%ofApoAinHDLisApoAI.LevelsofApoAIareinverselyrelatedtotheriskofcoronaryheartdisease.ApoAIisalsothoughttoactivateLCAT(lecithincholesterolacyltranferase).Innormalplasma,ApoAIlevelsrangefrom90-130mgper100ml.
Purity:>=95%bySDS-PAGE
PreparedfromplasmashowntobenonreactiveforHBsAg,anti-HCV,anti-HBc,andnegativeforanti-HIV1&2byFDAapprovedtests.
athensresearch&Technologyproductsarelaboratoryreagentsandarenottobeadministeredtohumansorusedforanydrugpurpose.Forresearchuseonly.
Haptoglobin,HumanPlasma,MixedType
触珠蛋白
ExtinctionCoefficient:1.20
Salt-freelyophilizedsolid.
Storage:-20°C
Anacute-phaseplasmaproteinfoundinhumanplasmaat100-300mgper100ml.Bindshemoglobin,thuspreventinglossofironthroughthekidneys.Humansarepolymorphicforhaptoglobin,withthreemajorphenotypes:Hp1-1,Hp2-1,andHp2-2.Whilethephenotypicdistributioncanvarygreatlybetweenethnicitiesandgeographiclocation,theHp2-1phenotypeisthemostprevalentphenotypeinhumans.PlasmaconcentrationsofhaptoglobinarehighestinindividualswithHp1-1,intermediateinHp2-1individuals,andlowestinHp2-2individuals.Hp1-1isthemosteffectiveatbindinghemoglobin,andHp2-2istheleasteffective.Thisfunctionaldifferencemaybeassociatedwiththefrequencyandseverityofepilepsyattacks,asresearchershavefoundacorrelationbetweenrecurringseizuresandtheHp2-2phenotype.
Purity:>=95%bySDS-PAGE
PreparedfromplasmashowntobenonreactiveforHBsAg,anti-HCV,anti-HBc,andnegativeforanti-HIV1&2byFDAapprovedtests.
AthensResearch&Technologyproductsarelaboratoryreagentsandarenottobeadministeredtohumansorusedforanydrugpurpose.Forresearchuseonly.
MyeloperoxidaseEnzymeImmunoassayKit
髓过氧化物酶免疫分析试剂盒
HumanMPOEIAKITFEATURES:
USE-MeasurehumanMPOinavarietyofmatricesSAMPLE-Serum,Platelet-PoorHeparinPlasma,Saliva,UrineorTissueCultureMediaSAMPLES/KIT-40induplicateSENSITIVITY-0.068ng/mLSTABILITY-liquidreagentsstableat4°CQUICKRESULTS-2.5HOURS
Myeloperoxidase(MPO)isatetramericheme-containingproteinabundantlyproducedinneutrophilgranulocyteswhereitplaysanimportantanti-microbialrole.DuringdegranulationMPOisreleasedintotheextracellularspace.There,aspartoftheneutrophils\"respiratoryburst”,itproduceshypochlorousacidfromhydrogenperoxideandCl–.MPOalsouseshydrogenperoxidetooxidizetyrosinetothetyrosylradical.Bothhypochlorousacidandtyrosylarecytotoxicandwhenpresentcankillbacteriaandotherpathogens.Hereditarydeficiencyofmyeloperoxidasepredisposesindividualstoimmunedeficiency.
StudieshaveshownanassociationbetweenelevatedMPOlevelsandcoronaryarterydisease,andin2003itwassuggestedthatMPOmayserveasasensitivepredictorofmyocardialinfarctioninpatientscomplainingofchestpain.SincethattimetheclinicalutilityofMPOtestingincardiacpatientshasbeensolidlyestablishedintheliteraturewithwellover100paperspublished.In2010thisclinicalapplicationwasfurtherrefinedbyadditionalstudieswhichdeterminedthatmeasuringbothMPOandC-reactiveprotein(CRP)providedmoreaccuratepredictionofmortalityriskthanmeasuringjustCRPalone.
Albumin,HumanPlasma | 16-16-011202 |
Alpha1AcidGlycoprotein,HumanPlasma | 16-16-010700 |
Alpha1Antichymotrypsin,HumanPlasma | 16-16-012400 |
Alpha1Antitrypsin,HumanPlasma | 16-16-011609 |
Alpha2Antiplasmin,HumanPlasma | 16-16-012901 |
Alpha2HSGlycoprotein,HumanPlasma | 16-16-081907 |
Alpha2Macroglobulin,HumanPlasma | 16-16-012013 |
Angiotensinogen,HumanPlasma | 16-16-011407 |
AntiseratoAlbumin,HumanPlasma | 01-16-011202 |
AntiseratoAmylase,HumanPancreas | 01-19-010000 |
AntiseratoApolipoproteinAI,HumanPlasma | 01-16-120101 |
AntiseratoApolipoproteinCII,HumanPlasma | 01-16-120302 |
AntiseratoAzurocidin,HumanNeutrophil | 01-14-012621 |
AntiseratoCatalase,HumanErythrocyte | 01-05-030000 |
AntiseratoCathepsinB,HumanLiver | 01-12-030102 |
AntiseratoCathepsinD,HumanLiver | 01-12-030104 |
AntiseratoCathepsinH,HumanLiver | 01-12-030108 |
AntiseratoCathepsinL,HumanLiver | 01-12-030112 |
AntiseratoElastase,HumanNeutrophil | 01-14-051200 |
AntiseratoFibrinogen,HumanPlasma | 01-16-060902 |
AntiseratoKallikrein,HumanPlasma | 01-16-110112 |
AntiseratoMyeloperoxidase,HumanNeutrophil | 01-14-130000 |
AntiseratoThrombospondin,HumanPlatelet | 01-20-201319 |
AntiseratoTrypsin,HumanPancreas | 01-19-032000 |
AntithrombinIII,HumanPlasma | 16-16-012020 |
ApolipoproteinAI,HumanPlasma | 16-16-120101 |
ApolipoproteinAII,HumanPlasma | 16-16-120102 |
ApolipoproteinAIV,HumanPlasma | 16-16-120104 |
ApolipoproteinB,HumanPlasma | 16-16-120200 |
ApolipoproteinCI,HumanPlasma | 16-16-120301 |
ApolipoproteinCII,HumanPlasma | 16-16-120302 |
ApolipoproteinCIII,HumanPlasma | 16-16-120303 |
ApolipoproteinE,HumanPlasma | 16-16-120500 |
Apotransferrin,DogPlasma | 16-16-A32001-dog |
Apotransferrin,HumanPlasma | 16-16-A32001 |
Apotransferrin,HumanPlasma,LowEndotoxinLevel | 16-16-A32001-LEL |
Apotransferrin,MousePlasma | 16-16-A32001-mouse |
Apotransferrin,RatSerum | 16-16-A32001-rat |
Azurocidin,HumanNeutrophil(Cationicprotein37) | 16-14-012621 |
Bacterial/Permeability-IncreasingProtein,HumanNeutrophil(BPI,CAP57) | 16-14-021609 |
C1EsteraseInhibitor,HumanPlasma | 16-16-031509 |
Calmodulin,BovineBrain,HighPurity | 16-BR-030112-HP-bovine |
Calpain-1,HumanErythrocyte | 16-05-030112 |
Calpain-1,PorcineErythrocytes | 16-05-030112-P |
Catalase,HumanErythrocyte | 16-05-030000 |
CathepsinB,BovineSpleen | 16-SP-030102-bovine |
CathepsinB,HumanLiver | 16-12-030102 |
CathepsinD,BovineSpleen | 16-SP-030104-bovine |
CathepsinD,HumanLiver | 16-12-030104 |
CathepsinG,HumanNeutrophil | 16-14-030107 |
CathepsinH,HumanLiver | 16-12-030108 |
CathepsinL,HumanLiver | 16-12-030112 |
CathepsinS,HumanSpleen | 16-18-030118 |
Ceruloplasmin,HumanPlasma | 16-16-030518 |
Chylomicrons,HumanPlasma | 12-16-030825 |
Chymotrypsin,HumanPancreas | 16-19-030820 |
Defensins,Alpha,MixedfromHumanNeutrophils(HNP) | 16-14-081416 |
DipeptidylPeptidaseIV,HumanPlacenta | 16-23-041606 |
Elastase,HumanNeutrophil | 16-14-051200 |
EosinophilCationicProtein,HumanEosinophils(ECP) | 16-15-050316 |
EosinophilDerivedNeurotoxin,HumanEosinophils(EDN) | 16-15-050414 |
EosinophilPeroxidase,HumanEosinophils(EPO) | 16-15-160518 |
FactorVa,HumanPlasma | 16-16-060601 |
GC-Globulin,HumanPlasma,MixedType(维D结合蛋白) | 16-16-070307 |
Haptoglobin,HumanPlasma,MixedType | 16-16-080116 |
Hemopexin,HumanPlasma | 16-16-080513 |
ImmunoglobulinA,HumanPlasma | 16-16-090701 |
ImmunoglobulinA1,HumanMyelomaProtein | 16-16-090701-1M |
ImmunoglobulinA2,HumanMyelomaPlasma | 16-16-090701-2M |
ImmunoglobulinD,HumanMyelomaPlasma | 16-16-090704-M |
ImmunoglobulinD,HumanPlasma | 16-16-090704 |
ImmunoglobulinE,HumanMyelomaPlasma | 16-16-090705-M |
ImmunoglobulinE,HumanPlasma | 16-16-090705 |
ImmunoglobulinG,DogPlasma | 16-16-090707-dog |
ImmunoglobulinG,HumanPlasma | 16-16-090707 |
ImmunoglobulinG,HumanPlasma,FabFragment | 16-16-090707-Fab |
ImmunoglobulinG,HumanPlasma,FCFragment | 16-16-090707-FC |
ImmunoglobulinG,MousePlasma | 16-16-090707-mouse |
ImmunoglobulinG,RatSerum | 16-16-090707-rat |
ImmunoglobulinG1,HumanMyelomaPlasma | 16-16-090707-1M |
ImmunoglobulinG2,HumanMyelomaPlasma | 16-16-090707-2M |
ImmunoglobulinG3,HumanPlasma | 16-16-090707-3 |
ImmunoglobulinG4,HumanMyelomaPlasma | 16-16-090707-4M |
ImmunoglobulinM,Fc5mu,HumanPlasma | 16-16-090713-Mfc5u |
ImmunoglobulinM,HumanMyelomaPlasma | 16-16-090713-M |
ImmunoglobulinM,HumanPlasma | 16-16-090713 |
ImmunoglobulinM,muChain,HumanPlasma | 16-16-090713-MU |
Kallikrein,HumanPlasma | 16-16-110112 |
Kininogen,HMW,HumanPlasma | 16-16-110914-H |
Kininogen,LMW,HumanPlasma | 16-16-110914-L |
Lactalbumin,HumanMilk | 13-16-011202 |
Lactoferrin,HumanNeutrophil | 16-14-120103 |
Lipoproteina,[Lp(a)],HumanPlasma | 12-16-121601 |
Lipoproteins,HighDensity,HumanPlasma | 12-16-080412 |
Lipoproteins,HighDensity,HumanPlasma,适于细胞培养 | 12-16-080412-TC |
Lipoproteins,IntermediateDensity,HumanPlasma | 12-16-090412 |
Lipoproteins,LowDensity,HumanPlasma | 12-16-120412 |
Lipoproteins,LowDensity,HumanPlasma,适于细胞培养 | 12-16-120412-TC |
Lipoproteins,VeryLowDensity,HumanPlasma | 12-16-221204 |
Lipoproteins,VeryLowDensity,HumanPlasma,适于细胞培养 | 12-16-221204-TC |
Lysozyme,HumanNeutrophil | 16-14-122519 |
Myeloperoxidase,HumanNeutrophil | 16-14-130000 |
Plasmin,HumanPlasma,Frozen | 16-16-161213-F |
Plasmin,HumanPlasma,Lyophilized | 16-16-161213-L |
Plasminogen,HumanPlasma | 16-16-161200 |
PlateletFactor4,HumanPlatelet | 16-20-060306 |
Prealbumin,HumanPlasma(Transthyretin) | 16-16-161801 |
Proteinase3,HumanNeutrophil | 16-14-161820 |
S-100Protein,BovineBrain | 16-BR-190816-bovine |
S-100bProtein,BovineBrain | 16-BR-190802-bovine |
S-100ααProtein,BovineBrain | 16-BR-190801-bovine |
SerumAmyloidA,HumanPlasma | 16-16-190101 |
Thrombospondin,HumanPlatelet | 16-20-201319 |
Transferrin,DogPlasma | 16-16-032001-dog |
Transferrin,HumanPlasma | 16-16-032001 |
Transferrin,HumanPlasma,组织培养级 | 16-16-032001-LEL |
Transferrin,MousePlasma | 16-16-032001-mouse |
Transferrin,RatSerum | 16-16-032001-rat |
Trypsin,HumanPancreas | 16-19-032000 |
Vitronectin,HumanPlasma | 16-16-220920 |
本文链接: http://athens.immuno-online.com/view-1449612392.html